Latest news with #HealthVerityMarketplace
Yahoo
13-05-2025
- Business
- Yahoo
Premier, Inc. named as data source in HealthVerity Marketplace™ to expand real-world data access for life sciences research
Integration delivers high-value datasets including chargemaster, laboratory results and EMR data to accelerate clinical and commercial insights PHILADELPHIA, May 13, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced the addition of Premier, Inc. (NASDAQ: PINC) to HealthVerity Marketplace™, meaning life sciences organizations using HealthVerity Marketplace™ can now access Premier's high-quality, healthcare data to support research across the product lifecycle. HealthVerity Marketplace is the nation's largest verified healthcare and consumer data ecosystem, offering access to over 340 million de-identified individuals and enabling precise patient journey insights through the HIPAA-compliant linkage of diverse data types. With the addition of Premier data, HealthVerity Marketplace users can now use the platform to discover and license inpatient and outpatient data that supports evidence generation across a wide range of use cases, including market access, clinical development, and epidemiological research. Premier data available through HealthVerity Marketplace includes inpatient and outpatient electronic medical record (EMR) data. This opens pathways for the inclusion of de-identified, unstructured clinical notes. These enhancements will enable researchers to further validate clinical insights and strengthen study design with previously unavailable data. The Premier® Healthcare Database (PHD) is one of the most comprehensive electronic healthcare data repositories and the largest inpatient and outpatient chargemaster database. For nearly 25 years, it has served as a valuable source of RWD for the pharmaceutical and medical device industries, academic institutions, government agencies, and hospitals and health systems. Researchers using the PHD can analyze device and drug utilization with greater specificity, uncover trends in resource use and outcomes, and generate insights into care quality, safety and cost. Premier also offers EMR chart retrieval and review services that support regulatory-grade research and verification needs. "Our sharp focus on differentiated data, leading-edge research and clinical trials innovation helps drive speed to value," said Denise Juliano, Premier Applied Sciences Group Vice President. "Having the right data is critical for life sciences organizations aspiring to create meaningful change in healthcare. "Premier's partnership with HealthVerity securely links Premier® data with other real-world datasets, expanding on its longitudinal view of the patient journey that helps measure the effectiveness, quality and cost of therapies." "We are thrilled to officially welcome Premier as a named partner in HealthVerity Marketplace," said Andrew Kress, CEO of HealthVerity. "Premier's extensive, high-quality data adds substantial value for pharmaceutical manufacturers and healthcare innovators. These precise clinical insights are essential for therapeutic advancements and targeted patient care strategies." About HealthVerity HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. To learn more, please visit HealthVerity contact:info@ About Premier, Inc. Premier, Inc. (NASDAQ: PINC) is a leading technology-driven healthcare improvement company, providing solutions to two-thirds of all healthcare providers in the U.S. Playing a critical role in the rapidly evolving healthcare industry, Premier unites providers, suppliers, payers and policymakers to make healthcare better with national scale, smarter with actionable intelligence and faster with novel technologies. Headquartered in Charlotte, N.C., Premier offers integrated data and analytics, collaboratives, supply chain solutions, consulting and other services in service of our mission to improve the health of communities. Please visit Premier's news and investor sites on as well as X, Facebook, LinkedIn, YouTube, Instagram and Premier's blog for more information about the company. Premier contact:Public_Relations@ View original content to download multimedia: SOURCE HealthVerity, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
16-04-2025
- Business
- Associated Press
HealthVerity Partners with Recursion to Enhance Clinical Trial Analytics with Real-World Data
PHILADELPHIA, April 16, 2025 /PRNewswire/ -- HealthVerity, the leader in real-world data (RWD) technology and privacy-compliant data exchange, today announced that Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, has licensed its real-world data to enhance clinical trial design and analytics. Through this agreement, Recursion will integrate HealthVerity de-identified data for over 340M covered lives within the US into its advanced data science and machine learning platforms, the Recursion OS, allowing for deeper insights into patient populations, enhanced trial design and feasibility assessments, as well as clinical operations workflows. By leveraging these high-quality, linked data assets, Recursion seeks to industrialize clinical development, reduce costs, and accelerate the development of novel therapeutics. 'Our partnership with Recursion underscores the transformative potential of real-world data in driving smarter clinical trials,' said Andrew Kress, CEO of HealthVerity. 'By providing seamless access to the industry's most comprehensive and interoperable real-world data, we empower innovators like Recursion to make data-driven decisions that streamline clinical development.' Recursion's proprietary AI-driven approach relies on integrating diverse datasets and AI/ML models to identify novel insights into human biology and molecule design. The incorporation of real-world data from HealthVerity Marketplace will further strengthen Recursion's ability to predict patient responses, refine study designs, and ensure clinical trial sites are positioned to meet enrollment goals. 'With the majority of the industry's time and resources focused on clinical trials, we see a significant opportunity to transform how clinical development is designed and executed,' said Najat Khan, PhD, Chief R&D Officer and Chief Commercial Officer at Recursion. 'By integrating privacy-compliant real-world data from HealthVerity into Recursion OS, we are advancing our mission to optimize trial design through in silico simulations, accelerate recruitment through a patient-centric approach that includes underserved populations, and generate stronger evidence to inform development and regulatory decisions. By doing so, we are not only streamlining clinical development but also ensuring that we bring more impactful, life-changing treatments to patients faster and more efficiently' The HealthVerity approach to real-world data acquisition and governance ensures compliance with HIPAA and other regulatory frameworks while maintaining the highest standards of patient privacy. By combining data from the nation's largest healthcare data ecosystem, HealthVerity enables precise patient journey insights, supporting clinical development, regulatory submissions, and post-market studies. For more information, visit About HealthVerity HealthVerity is the leader in privacy-protected real-world data exchange, transforming how healthcare and life sciences organizations connect and analyze disparate patient data. By enabling access to the industry's largest RWD ecosystem, HealthVerity supports critical applications in clinical development, commercial strategy, and regulatory decision-making. About Recursion Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine. Media Contact: HealthVerity [email protected] Recursion [email protected] View original content to download multimedia: SOURCE HealthVerity, Inc.
